FindTrial
Sign In

Clinical Outcomes of Malignant Biliary Obstruction Based on Real-world Data

Clinical Outcomes of Malignant Biliary Obstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055786
Enrollment
Unknown
Registered
2022-01-19
Start date
2022-01-19
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Biliary Obstruction

Interventions

Retrospective training group:Interventional drainage
Retrospective valiation group:Interventional drainage
Prospective validation group:Interventional drainage

Sponsors

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over; 2. Clinical or histopathological diagnosis of MBO; 3. Initially undergoing percutaneous approach for the placement of plastic catheters, or metal stents with or without iodine-125 seed strands.

Exclusion criteria

Exclusion criteria: 1. Surgical resection within 1 month before and after interventions; 2. Presence of severe symptoms before interventions, such as septic shock and organ failure; 3. ECOG PS score of 4 before interventions; 4. Loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Restenosis-free survival;Early biliary infection;postprocedural pancreatitis or abnormal elevation of serum amylaseor;—

Countries

China

Contacts

Public ContactZhou Haifeng

The First Affiliated Hospital of Nanjing Medical University

hfzhou_ir@sina.com+86 15298372811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026